Logo image of PAVS

PARANOVUS ENTERTAINMENT TECH (PAVS) Stock Fundamental Analysis

NASDAQ:PAVS - Nasdaq - KYG4289N2050 - Common Stock - Currency: USD

0.92  -0.05 (-5.17%)

After market: 0.96 +0.04 (+4.35%)

Fundamental Rating

2

Overall PAVS gets a fundamental rating of 2 out of 10. We evaluated PAVS against 35 industry peers in the Personal Care Products industry. PAVS has a great financial health rating, but its profitability evaluates not so good. PAVS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PAVS has reported negative net income.
In the past year PAVS has reported a negative cash flow from operations.
In multiple years PAVS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PAVS reported negative operating cash flow in multiple years.
PAVS Yearly Net Income VS EBIT VS OCF VS FCFPAVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

The Return On Assets of PAVS (-131.02%) is worse than 94.29% of its industry peers.
The Return On Equity of PAVS (-181.45%) is worse than 77.14% of its industry peers.
Industry RankSector Rank
ROA -131.02%
ROE -181.45%
ROIC N/A
ROA(3y)-126.38%
ROA(5y)-72.71%
ROE(3y)-243.06%
ROE(5y)-142.48%
ROIC(3y)N/A
ROIC(5y)N/A
PAVS Yearly ROA, ROE, ROICPAVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

PAVS has a worse Gross Margin (0.14%) than 88.57% of its industry peers.
In the last couple of years the Gross Margin of PAVS has declined.
PAVS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-82.38%
GM growth 5Y-69.23%
PAVS Yearly Profit, Operating, Gross MarginsPAVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

PAVS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PAVS has been reduced compared to 1 year ago.
Compared to 5 years ago, PAVS has more shares outstanding
There is no outstanding debt for PAVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PAVS Yearly Shares OutstandingPAVS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
PAVS Yearly Total Debt VS Total AssetsPAVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PAVS has an Altman-Z score of 6.72. This indicates that PAVS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.72, PAVS belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
PAVS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.72
ROIC/WACCN/A
WACC7.45%
PAVS Yearly LT Debt VS Equity VS FCFPAVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

PAVS has a Current Ratio of 1.11. This is a normal value and indicates that PAVS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PAVS (1.11) is worse than 65.71% of its industry peers.
A Quick Ratio of 1.11 indicates that PAVS should not have too much problems paying its short term obligations.
PAVS has a Quick ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
PAVS Yearly Current Assets VS Current LiabilitesPAVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.61% over the past year.
Looking at the last year, PAVS shows a very negative growth in Revenue. The Revenue has decreased by -93.33% in the last year.
Measured over the past years, PAVS shows a very negative growth in Revenue. The Revenue has been decreasing by -36.61% on average per year.
EPS 1Y (TTM)88.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.03%
Revenue 1Y (TTM)-93.33%
Revenue growth 3Y-54.93%
Revenue growth 5Y-36.61%
Sales Q2Q%-99.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PAVS Yearly Revenue VS EstimatesPAVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PAVS Yearly EPS VS EstimatesPAVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 5 10 15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAVS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PAVS Price Earnings VS Forward Price EarningsPAVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVS Per share dataPAVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PAVS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARANOVUS ENTERTAINMENT TECH

NASDAQ:PAVS (5/14/2025, 8:00:02 PM)

After market: 0.96 +0.04 (+4.35%)

0.92

-0.05 (-5.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-23.8%
Ins Owners2.06%
Ins Owner ChangeN/A
Market Cap61.95M
Analysts82.86
Price TargetN/A
Short Float %0.25%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.47
P/FCF N/A
P/OCF N/A
P/B 11.1
P/tB 86.51
EV/EBITDA N/A
EPS(TTM)-2.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.1
BVpS0.08
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -131.02%
ROE -181.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.14%
FCFM N/A
ROA(3y)-126.38%
ROA(5y)-72.71%
ROE(3y)-243.06%
ROE(5y)-142.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-82.38%
GM growth 5Y-69.23%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 6.72
F-Score3
WACC7.45%
ROIC/WACCN/A
Cap/Depr(3y)37.17%
Cap/Depr(5y)142.97%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-93.33%
Revenue growth 3Y-54.93%
Revenue growth 5Y-36.61%
Sales Q2Q%-99.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y95.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.69%
OCF growth 3YN/A
OCF growth 5YN/A